AbbVie (ABBV) Q4 2025 Earnings Call Transcript

Powered byQuartr

Company Participants

  • Operator
  • Liz Shea - SVP of Investor Relations, AbbVie
  • Rob Michael - Chairman and CEO, AbbVie
  • Jeff Stewart - EVP of Chief Commercial Officer, AbbVie
  • Roopal Thakkar - EVP, R&D, and Chief Scientific Officer, AbbVie
  • Scott Reents - EVP and CFO, AbbVie
  • David Risinger - Senior Managing Director, Leerink Partners
  • Chris Schott - Managing Director and Senior Equity Research Analyst, JPMorgan
  • Terence Flynn - Equity Research Analyst, Morgan Stanley
  • Asad Haider - Managing Director in Equity Research of Healthcare and Biotech Companies, Goldman Sachs
  • Vamil Divan - Managing Director and Senior Research Analyst, Guggenheim Securities
  • Steve Scala - Managing Director, TD Cowen
  • Mohit Bansal - Managing Director of Biopharma Equity Research, Wells Fargo
  • David Amsellem - Managing Director and Senior Research Analyst, Piper Sandler
  • Luisa Hector - Head of Global Pharma Equity Research, Berenberg
  • Michael Yee - Global Head of Biotechnology Equity Research and Managing Director, UBS
  • Mark Hoffman - Senior Equity Research Associate of BioPharma, BMO Capital Markets